Publication | Closed Access

Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis

Ligand CycloAutoimmune DiseaseMedicinePromising Drug LeadPharmacologyImmunologyPeptide TherapeuticAutoimmunityPeptide ScienceBrain-immune InteractionNeurologyMultiple SclerosisImmunosuppressionImmunotherapyNeuroimmunology